Merck uncomfortably numb after settlement

Share this article:

Merck, the manufacturer of painkiller Vioxx, has settled deceptive advertising charges for $58 million and agreed to submit all new television comĀ­mercials for its drugs to the Food and Drug Administration for review for the next seven years. The agency had challenged Merck's direct-to-consumer television ads, which began in 1999.

This material may not be published, broadcast, rewritten or redistributed in any form without prior authorization. Your use of this website constitutes acceptance of Haymarket Media's Privacy Policy and Terms & Conditions